🔗 Share this article

Chancellor Reeves has revealed she is preparing "focused steps to address household expense pressures" in the forthcoming Budget.

In comments to media outlets, she stated that reducing price rises is a collective responsibility of both the government and the central bank.

The UK's price growth is projected to be the most elevated among the Group of Seven developed nations this calendar year and the following year.

Possible Utility Cost Interventions

It is understood the government could take action to bring down utility costs, for example by cutting the present 5% level of VAT charged on energy supplies.

Another possibility is to lower some of the policy costs currently included in household expenses.

Fiscal Limitations and Analyst Predictions

The government will obtain the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much scope there is for these actions.

The consensus from the majority of experts is that Reeves will have to introduce higher taxes or expenditure reductions in order to fulfill her declared fiscal targets.

Previously on Thursday, estimates showed there was a £22 billion deficit for the chancellor to resolve, which is at the lower end of forecasts.

"There's a joint job between the Bank of England and the government to further reduce some of the causes of price increases," the Chancellor told the BBC in the US capital, at the conferences of the IMF and World Bank.

Tax Commitments and International Concerns

While a great deal of the focus has been on expected tax increases, the chancellor said the latest figures from the fiscal watchdog had not altered her vow to campaign commitments not to increase rates on income tax, sales tax or social security contributions.

She blamed an "unpredictable world" with rising international and trade tensions for the fiscal revenue measures, likely to be focused on those "most able to pay."

International Economic Disputes

Addressing concerns about the UK's economic relations with the Asian nation she said: "Our national security always are paramount."

Recent declaration by Chinese authorities to strengthen export controls on critical minerals and other resources that are crucial for high-technology production led US President Donald Trump to suggest an further 100% tariff on goods from China, raising the possibility of an all-out commercial conflict between the two global powers.

The US Treasury Secretary labeled the Chinese decision "economic coercion" and "a international production power grab."

Questioned on accepting the American proposal to participate in its battle with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese actions and urged the Beijing authorities "not to put up barriers and restrict access."

She said the action was "bad for the world economy and causes further challenges."

"In my view there are areas where we need to address Chinese policies, but there are also significant chances to trade with China's economy, including financial services and other areas of the economy. We've got to achieve that balance appropriate."

The chancellor also confirmed she was working with G7 counterparts "regarding our own essential resources strategy, so that we are reduced dependence."

Health Service Drug Costs and Funding

Reeves also admitted that the cost the National Health Service spends on medicines could go up as a consequence of current discussions with the US government and its drugs companies, in return for lower tariffs and funding.

A number of the biggest global drug companies have said in recent statements that they are either halting or abandoning projects in the United Kingdom, with some attributing the modest returns they are getting.

Last month, the government science advisor said the price the NHS pays for medicines would need to increase to prevent businesses and drug research funding leaving the United Kingdom.

Reeves stated to media: "It has been observed as a result of the cost structure, that medical research, new drugs have not been provided in the UK in the extent that they are in other continental states."

"Our aim is to ensure that patients getting care from the National Health Service are able to obtain the top essential treatments in the world. And so we are examining this situation, and... aiming to secure increased investment into the UK."